Mimedx (MDXG) Share-based Compensation Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -139.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -139.79% |
| Dec 31, 2025 | -47.52% |
| Sep 30, 2025 | 29.14% |
| Jun 30, 2025 | 16.16% |
| Mar 31, 2025 | -1.80% |
| Dec 31, 2024 | 7.00% |
| Sep 30, 2024 | -13.20% |
| Jun 30, 2024 | 0.76% |
| Mar 31, 2024 | 11.17% |
| Dec 31, 2023 | 727.55% |
| Sep 30, 2023 | 84.99% |
| Jun 30, 2023 | -8.31% |
| Mar 31, 2023 | -2.35% |
| Dec 31, 2022 | -82.57% |
| Sep 30, 2022 | -37.76% |
| Jun 30, 2022 | 9.06% |
| Mar 31, 2022 | 23.24% |
| Dec 31, 2021 | -22.13% |
| Sep 30, 2021 | 3.87% |
| Jun 30, 2021 | -8.43% |
| Mar 31, 2021 | -3.14% |
| Dec 31, 2020 | 36.30% |
| Sep 30, 2020 | 36.60% |
| Jun 30, 2020 | 26.72% |
| Mar 31, 2020 | 11.11% |
| Dec 31, 2019 | 96.64% |
| Sep 30, 2019 | -32.14% |
| Jun 30, 2019 | -20.87% |
| Mar 31, 2019 | -38.88% |
| Dec 31, 2018 | -75.57% |
| Sep 30, 2018 | -25.41% |
| Jun 30, 2018 | -15.85% |
| Mar 31, 2018 | 5.57% |
| Dec 31, 2017 | 52.66% |
| Sep 30, 2017 | 12.85% |
| Jun 30, 2017 | 16.54% |
| Mar 31, 2017 | 1.21% |
| Dec 31, 2016 | -9.83% |
| Sep 30, 2016 | 7.40% |
| Jun 30, 2016 | 6.02% |
| Mar 31, 2016 | 17.34% |
| Dec 31, 2015 | 31.59% |
| Sep 30, 2015 | 44.87% |
| Jun 30, 2015 | 53.70% |
| Mar 31, 2015 | 65.81% |
| Dec 31, 2014 | 77.47% |
| Sep 30, 2014 | 81.20% |
| Jun 30, 2014 | 84.17% |
| Mar 31, 2014 | 140.86% |
| Dec 31, 2013 | 136.81% |
| Sep 30, 2013 | 149.12% |
| Jun 30, 2013 | 156.73% |
| Mar 31, 2013 | 96.57% |
| Dec 31, 2012 | 24.97% |
| Sep 30, 2012 | 200.49% |
| Jun 30, 2012 | 36.38% |
| Mar 31, 2012 | 31.71% |